Effect of MYCN Amplification on Tumor Response and Recurrence in Patients With Stage IV Neuroblastoma
JCO Precision Oncology · 2026-03 · 10 (3)
DOI: 10.1200/po-25-00635 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCO Precision Oncology, 2026-03. Verfasst von Yvette A H Matser und 12 weiteren Autor:innen. Beteiligte Einrichtung: Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. Hauptthemen laut MEDLINE: Neuroblastoma, N-Myc Proto-Oncogene Protein, Gene Amplification, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
PURPOSE MYCN amplification ( MYCN -A) is an important prognostic marker in neuroblastoma. However, the impact of MYCN -A in patients with metastasized high-risk neuroblastoma during the course of disease remains unclear. The aim of this study was to investigate response and relapse patterns of stage IV patients with and without amplification of MYCN . MATERIALS AND METHODS Amplification of the MYCN oncogene was assessed by fluorescence in situ hybridization, whole exome sequencing, or single nucleotide polymorphism analysis. Complete remission (according to the revised International Neuroblastoma Response Criteria) and survival outcomes were estimated. RESULTS Among the 164 patients older than 12 months with metastatic high-risk neuroblastoma, 50 (30%) had MYCN -A. MYCN -A was a significant prognostic marker for overall survival ( P = .04). Patients with MYCN -amplified tumors reached complete remission faster compared with those without MYCN amplification (HR, 1.8 [95% CI, 1.2 to 2.8]; P < .01). MYCN -A was associated with recurrence when evaluated from diagnosis and after induction treatment (HR, 1.6 [95% CI, 1.0 to 2.4]; and HR, 1.8 [95% CI, 1.1 to 2.8], respectively), as well as to the cumulative incidence of recurrence ( P = .04 and P = .03, respectively). SIOPEN scores detected on meta -[ 123 I]iodobenzylguanidine (MIBG) scintigraphy were significantly lower in patients with MYCN -amplified tumors than in patients with MYCN nonamplified tumors at diagnosis and after induction treatment ( P < .01 and P = .01, respectively). From end of induction, MYCN -A stratified by SIOPEN score was associated with the cumulative incidence of recurrence ( P < .01). CONCLUSION Despite achieving complete remission faster, patients with MYCN -A have a higher probability of recurrence compared with those without MYCN -A.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
- Laboratory Genetic Metabolic Diseases, Amsterdam UMC Location Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
- Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, the Netherlands.
- Division of Imaging and Oncology, University Medical Center, Utrecht, the Netherlands.
- Section Medical Statistics, Department of Biomedical Data Science, Leiden University Medical Center, Leiden, the Netherlands.
- Mathematical Institute, Leiden University, Leiden, the Netherlands.
ORCID-Profile: Yvette A H Matser, André B P van Kuilenburg, Atia Samim, Lotte M van Liempt, Martine van Grotel, Natasha K A van Eijkelenburg, Karin P S Langenberg, Max M van Noesel, Marta Fiocco, Godelieve A M Tytgat
Zitieren
APA
Matser, Y. A. H., van Kuilenburg, A. B. P., Samim, A., van Liempt, L. M., van Grotel, M., Kraal, K. C. J. M., Dierselhuis, M. P., van Eijkelenburg, N. K. A., Langenberg, K. P. S., van Noesel, M. M., Molenaar, J., Fiocco, M., & Tytgat, G. A. M. (2026). Effect of MYCN Amplification on Tumor Response and Recurrence in Patients With Stage IV Neuroblastoma. JCO Precision Oncology, 10(3). https://doi.org/10.1200/po-25-00635
Vancouver
Matser YAH, van Kuilenburg ABP, Samim A, van Liempt LM, van Grotel M, Kraal KCJM, et al. Effect of MYCN Amplification on Tumor Response and Recurrence in Patients With Stage IV Neuroblastoma. JCO Precision Oncology. 2026;10(3). doi:10.1200/po-25-00635
BibTeX
@article{Matser2026,
author = {Matser, Yvette A H and van Kuilenburg, André B P and Samim, Atia and van Liempt, Lotte M and van Grotel, Martine and Kraal, Kathelijne C J M and Dierselhuis, Miranda P and van Eijkelenburg, Natasha K A and Langenberg, Karin P S and van Noesel, Max M and Molenaar, Jan and Fiocco, Marta and Tytgat, Godelieve A M},
title = {Effect of MYCN Amplification on Tumor Response and Recurrence in Patients With Stage IV Neuroblastoma},
journal = {JCO Precision Oncology},
year = {2026},
volume = {10},
number = {3},
doi = {10.1200/po-25-00635}
}
EUVIMED